Nanotech Experts Question Whether Regulatory “Gaps” Affect Consumers

Nanotechnology experts, speaking at a meeting organized for FDA's Internal Nanotechnology Task Force, debated whether gaps in FDA's regulation of the technology actually represent problems for the industry and consumers

More from Archive

More from Pink Sheet